Vicore Pharma AB’s Post

New podcast: A new paradigm of appetite and hunger In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.  In this episode, Megan Thomas is in conversation with Tien Lee, CEO of Aardvark Therapeutics, a San Diego-based biotech company in Phase II studies of its drug, ARD-101, a type 2 bitter taste receptor (TAS2R) which is taken orally and remains in the human gut unlike GLP-1 which is systemic. The drug targets receptors in the gut where it triggers cholecystokinin (CCK), a GI system peptide hormone responsible for stimulating the digestion of fat and protein. CCK stimulates pancreatic secretion and gallbladder contraction, regulation of gastric emptying, and sends a signal to the brain that one has had enough to eat. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. https://lnkd.in/eeM7bp5j #DrugDiscovery #Obesity #DrugDevelopment

🚀 15-Minute Weekly Roundup: Insights for the Business Week Ended March 8, 2024 🔍 Another fantastic episode by Ian Haydock! Let’s dive into the key highlights: - Bayer AG: No Split (for Now) Despite speculation, Bayer AG has decided to remain intact. The company won’t split at this time. - Pfizer Inc.'s Next-Gen ADC Pipeline Pfizer is making strides in the field of antibody-drug conjugates (ADCs). Exciting developments lie ahead! - Oncology Dominates Investment Investors continue to pour resources into oncology research and development. A trend that shows no signs of slowing down. - Goodbye NASH, Hello MASH The focus is shifting from Non-Alcoholic Steatohepatitis (NASH) to Metabolic Associated Steatohepatitis (MASH). Keep an eye on this transition. - Bristol Myers Squibb CEO’s Views on India Insights from the top! The CEO of Bristol Myers Squibb shares perspectives on the Indian market.

#ICYMI Episode 8 of the Eight Drugs a Week podcast is out! #Florian and I speak to IATDMCT VIPs, Jan-Willem Alffenaar and Christophe Stove, about microsampling. This one is titled 'Got to get you into my life!' 🎯 🎵   #eightdrugsaweekpodcast #podcast #beatles #clinicalpharmacology #micorsampling #dbs #vams  

Did you miss our last DMPK Insights podcast on DMPK past, present and future? Listen to the episode here: https://lnkd.in/dh--ZvUd In this podcast, Phil Jeffrey (Bicycle Therapeutics), Beth Williamson PhD (UCB) and Daniel Price (Nimbus) discuss the evolution of DMPK as a predictive discipline that links the chemistry of drug design with the biology of drug disposition and effect. Learn more about the DMPK Insights podcast series here: https://lnkd.in/dkjW9BfX #DMPK #DMPKinsights #podcast #drugdesign

To ease you in to a new month you can listen to a podcast from CPHI featuring the dulcet (and incredibly knowledgeable) tones of Louise Duffy and Campbell Bunce. Why should you listen? ✅ To get a really clear overview of drug development and manufacturing of ADCs ✅ To understand the considerations for every step of the process at the micro and macro scale ✅ Learn more about key areas for innovation and expand your knowledge in the field ✅ To tap into the brains of two top industry professionals with over 50 years of cumulative experience! Listen now >> https://lnkd.in/eeapuBX2 #adcs #bioconjugation #drugdevelopment #cphi

A Focus on Men’s Health! I am excited to share this week's Life Science Podcast featuring an interview with Fady Boctor, MBA President and Chief Commercial Officer at Petros Pharmaceuticals. In the episode, Fady discussed Petros Pharma’s lead ED therapeutic and its potential to be transitioned to OTC status. He also discussed the overarching challenges in men’s health today and how Petros is positioned to tackle them. #lifescience #podcast #menshealth #reproductivehealth

2023 went by so quickly! If you missed it, be sure to catch the Bruker omg OMx podcast series where you meet the people behind the groundbreaking discoveries and their journey in mass spectrometry. Listen now: https://lnkd.in/e2xeH2hz #podcast #massspectrometry #proteomics #metabolomics #pharma #maldiimaging

If you wonder about the HPV vaccine market and how Merck becomes the No.1in China, listen to this Citeline #podcast by Ian Haydock and check out the story while you are there!

While other microbiome-targeting companies are turning out the lights, MaaT Pharma is moving briskly through a #Phase3 trial. How? Even founder and CEO Herve Affagard, MBA, Eng. says investors often chuckle and move on when they learn you believe gut health offers a promising path to cure cancers and treat #ALS. Out today on the #BusinessOfBiotech, Affagard lays out a combination that has led his young French company to this point, including overcoming an #FDA clinical hold. • A good story and the ability to tell it well. • Strong data. • Support from doctors who want to enroll patients. • A high tolerance for failure and persistence to move beyond it. Listen on Apple Podcasts, Google Podcasts, Spotify, or online. Produced in partnership with Cytiva.

New week and that means a new episode of "Måndagsaktier" is out 📈 This week we talked about the current financial situation but also made an analysis and compared Novo Nordisk and Astra Zeneca 💊 Two scandinavian giants who is undoubtedly essential for our global pharmaceutical development! I also wanted to let you know that i'm joining the Feminvest podcast this week! Talking Life Science, Birkenstock & Rusta IPO together with Michaela Berglund 🎙 Tune in and listen to my podcast debut! #feminvest #lifescience #acceleratefemaleownership #podcast